Sylvain Molon-Noblot

Author

MSD (France)

Also Known As

S Molon-Noblot, S. Molon-Noblot, S. Molon‐Noblot, Sylvain M. Molon-Noblot, Sylvain Molon-Noblot

Publications

483

Citations

H-Index

Concepts

All Affiliations

MSD (France)United States Military Academy Merck & Co., Inc., Rahway, NJ, USA (United States)MSD (UK) Limited (United Kingdom)

About

Sylvain Molon-Noblot is an author at MSD (France) specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	263
2	Endocrinology	4	4	126
3	Health Sciences	2	2	62
4	Social Sciences	1	1	46
5	Diabetes	1	1	36

Sylvain Molon-Noblot

Publications

420

Citations

H-Index

Page 1

	Year	Citations
Evidence for Peroxisome Proliferator-Activated Receptor (PPAR)α-Independent Peroxisome Proliferation: Effects of PPARγ/δ-Specific Agonists in PPARα-Null Mice John G. DeLuca, Thomas W. Doebber, Linda J Kelly, Molecular Pharmacology	2000	53
Mechanisms of action of the antidepressants fluoxetine and the substance P antagonist L-000760735 are associated with altered neurofilaments and synaptic remodeling Paul C. Guest, Michael R. Knowles, Sylvain Molon-Noblot, Brain Research Synaptic PlasticityMolecular NeurosciencePsychiatryNeurophysiologyMedicine	2004	46
Brain and optic system pathology in hypocholesterolemic dogs treated with a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase. P. H. Berry, J. S. Macdonald, A W Alberts, PubMed	1988	41
Effects of acetylcysteine on rabbit conjunctival and corneal surfaces. A scanning electron microscopy study. Florence Thermes, Sylvain Molon-Noblot, Jeffrey Grove PubMed Corneal SurfacesElectron MicroscopyOphthalmologyCorneal DystrophyMedicine	1991	40
The Effects of Ad Libitum Overfeeding and Moderate and Marked Dietary Restriction on Age-Related Spontaneous Pancreatic Islet Pathology in Sprague—Dawley Rats Sylvain Molon-Noblot, Kevin P. Keenan, John B. Coleman, Toxicologic Pathology NutritionAd Libitum OverfeedingCaloric RestrictionExperimental NutritionInsulin Signaling	2001	36
Quantitative evaluation of glandular and stromal compartments in hyperplastic dog prostates: Effect of 5‐alpha reductase inhibitors P. A. Laroque, S. Prahalada, Sylvain Molon-Noblot, The Prostate Animal PhysiologyQuantitative EvaluationUrologyReductase InhibitorsMedicine	1995	34
Recombinant Rat and Mouse Growth Hormones: Risk Assessment of Carcinogenic Potential in 2-Year Bioassays in Rats and Mice Georgia M. Farris, Glen K. Miller, Gordon K. Wollenberg, Toxicological Sciences Active Growth Hormone2-Year BioassaysDevelopmental BiologyGrowth HormoneHuman Growth	2007	30
The Morphology of Juxtaglomerular Cell Hyperplasia and Hypertrophy in Normotensive Rats and Monkeys Given an Angiotensin II Receptor Antagonist Sylvain Molon-Noblot, Marie-Françoise Hubert, M. Victoria Kindt, Toxicologic Pathology	1995	28
Effect of Chronic Growth Hormone Administration on Skeletal Muscle in Dogs Sylvain Molon-Noblot, Philippe Laroque, S. Prahalada, Toxicologic Pathology Animal PhysiologyMetabolic SyndromeVeterinary PhysiologyMuscle FunctionBody Composition	1998	26
Rat Urinary Bladder Hyperplasia Induced by Oral Administration of Carbonic Anhydrase Inhibitors Sylvain Molon-Noblot, Christine Boussiquet-Leroux, E. Irisarri, Toxicologic Pathology Carbonic Anhydrase InhibitorsUrologyUrological ResearchVoiding DysfunctionElectron Microscopy	1992	19

Page 1